ARTERIVAC

Inactivated vaccine adjuvanted with aluminum hydroxide for the prevention of viral arteritis equin

Inactivated equine viral arteritis virus: minimum 108
DECP50/ml before

inactivation.

Pharmaceutical form:

Suspension for injection.

Indications:

Prevention by active immunization of equines against

equine viral arteritis.

Administration:

Intramuscular route.

Vacation dose: 2 ml.